The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

Amid growing pressure on the U.S. healthcare system to meet the needs of its aging population, the Digital Medicine Society (DiMe) launched a new initiative this month to build a roadmap for ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

As the nation’s healthcare industry continues to struggle with workforce shortages and access gaps, Philips is expanding beyond its traditional medtech roots. The company isn’t just selling monitoring ...

About one in six working adults in the U.S. battle a substance use disorder, and nearly 10% of U.S. employees have a cannabis or stimulant use disorder. Recognizing this, Carrum Health has expanded ...

How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...

From Left to Right: Arundhati Parmar, editor-in-chief, MedCity News; Dickon Waterfield, president, Lantern; Darcy Sementi, healthcare benefits manager, State Farm ...

Almost 40,000 people have signed a petition calling on employers to provide comprehensive obesity care coverage. The petition came from the Alliance for Women’s Health and Prevention’s (AWHP) ...

Numerous efforts have been made at the federal level to crack down on the opaque business practices of pharmacy benefit managers, from a lawsuit by the Federal Trade Commission to bills in Congress.

Healthcare’s relationships with AI and digital transformation are a mix of excitement and uncertainty. Even as hospitals begin to see returns on their technology deployments, leaders acknowledge that ...

GSK finally has the long-awaited FDA approval it sought for blood cancer drug Blenrep. Three years after the pharmaceutical giant pulled the multiple myeloma therapy from the market, the FDA approved ...